Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenue, net $ 4,202 $ 3,316 $ 11,527 $ 9,963
Cost of revenue (excluding amortization of $813 and $970 for the three months and $2,439 and $2,909 for the nine months, respectively) 2,069 1,846 5,719 4,866
Gross profit 2,133 1,470 5,808 5,097
Operating expenses:        
Sales and marketing 1,816 1,282 4,507 4,186
Research and development 483 659 1,202 1,339
General and administrative 2,116 2,858 6,431 7,655
Acquisition related amortization expense 813 970 2,439 2,909
Asset impairment 3,363 3,363
Change in fair value of contingent consideration (1,174) (5,776) (1,174)
Total operating expenses 5,228 7,958 8,803 18,278
Operating loss (3,095) (6,488) (2,995) (13,181)
Interest expense (40) (539) (433) (1,601)
Loss on extinguishment of debt (4,278)
Other (loss) income, net (294) 4 (414) 14
Loss from continuing operations before tax (3,429) (7,023) (8,120) (14,768)
(Benefit) provision for income taxes (42) 173 (340) (54)
Loss from continuing operations (3,387) (7,196) (7,780) (14,714)
Income (loss) from discontinued operations, net of tax 71 (297) 572 101
Net loss (3,316) (7,493) (7,208) (14,613)
Net Loss and Comprehensive Loss $ (3,316) $ (7,493) $ (7,208) $ (14,613)
Basic and Diluted (loss) income per share of common stock:        
From continuing operations $ (0.15) $ (3.96) $ (0.65) $ (8.16)
From discontinued operations 0.00 (0.16) 0.05 0.06
Net loss per basic and diluted share of common stock $ (0.15) $ (4.13) $ (0.60) $ (8.10)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 22,028,000 1,816,000 12,022,000 1,803,000
Diluted 22,028,000 1,816,000 12,022,000 1,803,000